Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)
ECE50
1 other identifier
observational
384
1 country
1
Brief Summary
The objective of this registry is to confirm the safety and the performance of the ECE50 in medical routine by collecting data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 16, 2021
CompletedFirst Submitted
Initial submission to the registry
December 22, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 16, 2031
January 16, 2026
January 1, 2026
5.1 years
December 22, 2021
January 15, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Confirm the safety
Adverse event report analysis
Immediately after the intervention
Assess the performance of the ECE50
Comparison between the result of the ECE50 stimulation, Laryngeal Electromyography (LEMG), videolaryngoscopy
During the intervention
Secondary Outcomes (1)
Standardize the medical procedure for the ECE50
Immediately after the intervention
Eligibility Criteria
* Target population: adults of both sexes who, in the expert opinion of the registry responsible is in need of an ECE50 examination * Accessible population: target population matching the selection criteria * Intended population: accessible population that can be recruited by the registry sites * Actual population: intended population who signed the ICF * Analytic population: actual population compatible with PP analysis
You may qualify if:
- Legal adults (i.e., as a general rule patients ≥ 18 years old)
- Legal adults requiring a diagnosis for a disorder that could be traced back to uni- or bilateral dysfunction of one or more laryngeal muscle(s) of the posterior cricoid region
- Signed and dated informed consent before the start of any registry-specific procedure for all the recruited subjects
You may not qualify if:
- Use of an active medical implant
- Known allergies or intolerance to the material used for this registry
- Parallel participation in a device/drug registry in the period of data collection, which could confound the results of the registry
- Anything that, in the opinion of the Registry Responsible, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univ. Klinik für Hals-, Nasen- und Ohrenkrankheiten
Vienna, 1090, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Berit Schneider-Stickler, Prof.Dr.med.
Univ. Klinik für Hals-, Nasen- und Ohrenkrankheiten, Vienna
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 22, 2021
First Posted
February 18, 2022
Study Start
December 16, 2021
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
December 16, 2031
Last Updated
January 16, 2026
Record last verified: 2026-01